Pharmaceutical stocks are likely to get off to a strong start, buoyed by hopes on new drugs and expanded global business.
The share prices of Ilyang Pharmaceutical rose to 60 percent on January 5 compared with its shares in December, by expectations that its new drug for myelogenous leukemia may help lift earnings.
Shares of Dong-A, Hanmi, Bukwang Green Cross and Yuhan will also benefit f...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.